Polypharmacy and adults 65+: what matters
29.7% of Spaniards 65+ take five or more drugs concurrently, with similar estimates in Russia
Quick answer
The 65+ rule: drug count is not the threat – the sum of effects in the same systems is. Three drugs with anticholinergic load are more dangerous than ten drugs from different classes. Beers Criteria 2023 and STOPP/START v3 flag as potentially inappropriate: long-acting benzodiazepines, first-generation antihistamines, amitriptyline, megestrol, short-acting nifedipine, ergot derivatives. Safe alternatives exist for almost every case – discuss with the prescribing clinician or clinical pharmacist.
The real problem is not the number of drugs but additive effects: three drugs with anticholinergic activity summate to delirium; antihypertensives plus an alpha-blocker plus a hypnotic add up to a fall and a hip fracture. This selection is built from the Evigrade database with tags across 12 elderly risk classes.
Risk classes that summate in older adults
Drugs grouped by pharmacologicTags – tags for additive effects. Two or more drugs from the same group multiply the risk non-linearly. Each card shows the mechanism and management.
Hepatotoxicity (64)
Bleeding risk (59)
Orthostatic hypotension (47)
Serotonergic activity (42)
Hyperkalemia risk (35)
- Amlodipine + Olmesartan
- Amlodipine + Olmesartan + Hydrochlorothiazide
- Amlodipine + Valsartan
- Amlodipine + Valsartan + Hydrochlorothiazide
- Azilsartan medoxomil
- Azilsartan medoxomil + chlorthalidone
- Candesartan
- Candesartan + Hydrochlorothiazide
- Captopril
- Ciclosporin
- Co-trimoxazole
- Drospirenone + ethinylestradiol
Anticholinergic burden (32)
Hypokalemia risk (31)
Common conditions after 65
Conditions that form the core of geriatric polypharmacy: hypertension, type 2 diabetes, insomnia, falls. Each section lists drugs with elderly-specific notes from evidence-based guidelines.
Falls prevention in older adults (1)
Insomnia in older adults (3)
Isolated systolic hypertension in the elderly (1)
Type 2 diabetes in elderly patients (1)
Frequently asked
What is polypharmacy and at what drug count does it start?
Most geriatric societies (AGS, EuGMS, SEMEG) define polypharmacy as five or more concurrently prescribed drugs. Hyperpolypharmacy is ten or more. Polypharmacy itself is not bad if every drug is justified. The problem is potentially inappropriate medications (PIM), captured by Beers Criteria, STOPP/START and regular deprescribing reviews.
Which drug classes are most dangerous after 65?
Benzodiazepines and Z-drugs (fall risk and hip fracture up 1.5–2-fold), anticholinergics of any class (first-generation antihistamines, amitriptyline, oxybutynin, tolterodine – linked to dementia with cumulative exposure), NSAIDs in CKD and peptic ulcer, first-generation antipsychotics in dementia, long sulfonylureas (glibenclamide) with hypoglycemia.
Can melatonin and prescription hypnotics be taken together?
Not recommended. Melatonin is a weak sedative, but combined with zolpidem, zopiclone, doxylamine or antihistamines it adds to CNS load. In older adults this raises the risk of nighttime falls, morning confusion, orthostatic hypotension. If insomnia is chronic, options are CBT-I, removing evening caffeine and alcohol, ruling out sleep apnea.
How often should the drug list of an older patient be reviewed?
At minimum yearly for a stable patient and at every hospital admission or major change in status. The approach is called medication review or deprescribing review. A 2023 Cochrane review showed that systematic review cuts potentially inappropriate prescriptions by 35–60% without worsening clinical outcomes.
How Evigrade helps in geriatrics
Most Beers tools work as a lookup table: input a drug, get a red or green flag. Evigrade scores the regimen as a whole: it adds supplements (melatonin, valerian, St John’s wort) and cosmetic ingredients with systemic absorption (tretinoin, hydroquinone) and tallies the additive load across 12 pharmacologic classes. This covers a real scenario: a 78-year-old with hypertension, type 2 diabetes and insomnia on seven drugs plus bedtime melatonin – you need to know what adds up.
Primary sources
AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults 2023, STOPP/START criteria v3 2023, AEMPS, ESC Guidelines for Hypertension 2024, ADA Standards of Care 2025 (geriatrics section), SNS Plan de Acción frente a la polifarmacia 2025–2027.